Canada Life’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $593K | Hold |
30,216
| – | – | ﹤0.01% | 1466 |
|
|
2025
Q4 | $809K | Hold |
30,216
| – | – | ﹤0.01% | 1428 |
|
|
2025
Q3 | $813K | Hold |
30,216
| – | – | ﹤0.01% | 1492 |
|
|
2025
Q2 | $694K | Sell |
30,216
-1,046
| -3% | -$26K | ﹤0.01% | 1531 |
|
|
2025
Q1 | $907K | Sell |
31,262
-3,783
| -11% | -$121K | ﹤0.01% | 1461 |
|
|
2024
Q4 | $1.3M | Sell |
35,045
-1,902
| -5% | -$87K | ﹤0.01% | 1402 |
|
|
2024
Q3 | $1.79M | Sell |
36,947
-12,175
| -25% | -$534K | ﹤0.01% | 1336 |
|
|
2024
Q2 | $1.97M | Buy |
49,122
+9,192
| +23% | +$381K | ﹤0.01% | 1288 |
|
|
2024
Q1 | $1.75M | Buy |
39,930
+9,037
| +29% | +$467K | ﹤0.01% | 1306 |
|
|
2023
Q4 | $1.91M | Sell |
30,893
-2,424
| -7% | -$127K | ﹤0.01% | 1268 |
|
|
2023
Q3 | $1.53M | Buy |
33,317
+780
| +2% | +$42.5K | ﹤0.01% | 1335 |
|
|
2023
Q2 | $1.87M | Sell |
32,537
-2,953
| -8% | -$131K | ﹤0.01% | 1242 |
|
|
2023
Q1 | $1.33M | Sell |
35,490
-2,475
| -7% | -$81.1K | ﹤0.01% | 1403 |
|
|
2022
Q4 | $1.06M | Sell |
37,965
-4,402
| -10% | -$128K | ﹤0.01% | 1497 |
|
|
2022
Q3 | $1.19M | Buy |
42,367
+4,855
| +13% | +$159K | ﹤0.01% | 1419 |
|
|
2022
Q2 | $1.3M | Buy |
37,512
+5,236
| +16% | +$187K | ﹤0.01% | 1369 |
|
|
2022
Q1 | $1.19M | Sell |
32,276
-215
| -0.7% | -$6.1K | ﹤0.01% | 1465 |
|
|
2021
Q4 | $756K | Sell |
32,491
-203
| -0.6% | -$4.15K | ﹤0.01% | 1611 |
|
|
2021
Q3 | $627K | Buy |
32,694
+2,244
| +7% | +$43.9K | ﹤0.01% | 1671 |
|
|
2021
Q2 | $614K | Hold |
30,450
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q1 | $557K | Sell |
30,450
-4,843
| -14% | -$90.1K | ﹤0.01% | 1723 |
|
|
2020
Q4 | $710K | Sell |
35,293
-5,216
| -13% | -$102K | ﹤0.01% | 1645 |
|
|
2020
Q3 | $760K | Sell |
40,509
-824
| -2% | -$16.6K | ﹤0.01% | 1522 |
|
|
2020
Q2 | $927K | Sell |
41,333
-2,257
| -5% | -$41.3K | ﹤0.01% | 1475 |
|
|
2020
Q1 | $642K | Buy |
43,590
+505
| +1% | +$8.79K | ﹤0.01% | 1505 |
|
|
2019
Q4 | $824K | Buy |
+43,085
| New | +$826K | ﹤0.01% | 1570 |
|
|
2019
Q3 | – | Sell |
-46,463
| Closed | -$979K | – | 1165 |
|
|
2019
Q2 | $979K | Hold |
46,463
| – | – | ﹤0.01% | 1546 |
|
|
2019
Q1 | $949K | Buy |
46,463
+2,600
| +6% | +$58.2K | ﹤0.01% | 1402 |
|
|
2018
Q4 | $804K | Hold |
43,863
| – | – | ﹤0.01% | 1490 |
|
|
2018
Q3 | $844K | Hold |
43,863
| – | – | ﹤0.01% | 1590 |
|
|
2018
Q2 | $669K | Hold |
43,863
| – | – | ﹤0.01% | 1666 |
|
|
2018
Q1 | $822K | Sell |
43,863
-2,474
| -5% | -$46.5K | ﹤0.01% | 1577 |
|
|
2017
Q4 | $891K | Hold |
46,337
| – | – | ﹤0.01% | 1559 |
|
|
2017
Q3 | $828K | Sell |
46,337
-4,537
| -9% | -$74.6K | ﹤0.01% | 1581 |
|
|
2017
Q2 | $908K | Hold |
50,874
| – | – | ﹤0.01% | 1553 |
|
|
2017
Q1 | $738K | Buy |
50,874
+5,841
| +13% | +$91.8K | ﹤0.01% | 1604 |
|
|
2016
Q4 | $829K | Sell |
45,033
-4,000
| -8% | -$77.8K | ﹤0.01% | 1551 |
|
|
2016
Q3 | $930K | Buy |
49,033
+42,333
| +632% | +$768K | ﹤0.01% | 1470 |
|
|
2016
Q2 | $108K | Hold |
6,700
| – | – | ﹤0.01% | 2073 |
|
|
2016
Q1 | $80K | Hold |
6,700
| – | – | ﹤0.01% | 1911 |
|
|
2015
Q4 | $95K | Hold |
6,700
| – | – | ﹤0.01% | 1792 |
|
|
2015
Q3 | $78K | Hold |
6,700
| – | – | ﹤0.01% | 1868 |
|
|
2015
Q2 | $117K | Buy |
+6,700
| New | +$104K | ﹤0.01% | 1745 |
|
Other funds holding AMPH
VCM
BTW
Canada Life's AMPH Position: Q1 2026 in Review
Canada Life held its Amphastar Pharmaceuticals (AMPH) position steady in Q1 2026 at 30,216 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.
Canada Life first reported a position in AMPH in Q2 2015 and has held it in 43 quarters since. The position peaked at $1.97M in Q2 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Canada Life held 30,216 shares of Amphastar Pharmaceuticals worth $593K as of Q1 2026.
- Canada Life left its Amphastar Pharmaceuticals share count unchanged in Q1 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1466 holding.
- Canada Life first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 43 quarters since.
- Canada Life's Amphastar Pharmaceuticals position peaked at $1.97M in Q2 2024.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.